Patent · US Active

Substituted azoanthracene derivatives and intermediates for preparation thereof

US9175003B2 · kind B2 · utility

1Cited by

6References

11Claims

0Family size

Assignee

VTV THERAPEUTICS LLC · US

Inventors

Adnan M. M. Mjalli · Oak Ridge, US
Christopher Behme · Jamestown, US
Daniel P. Christen · High Point, US
Devi Reddy Gohimukkula · Jamestown, US
Dharma Rao Polisetti · High Point, US
James C. Quada, Jr. · San Antonio, US
Jennifer Freeman · Winston-Salem, US
Muralidhar Bondlela · Greensboro, US
Mustafa Guzel · Jamestown, US
Ravindra Reddy Yarragunta · Greensboro, US
Robert Carl Andrews · Jamestown, US
Santhosh Kalpathy · Jamestown, US
Stephen Thomas Davis · Durham, US
Thomas Scott Yokum · Greensboro, US

Key dates

Filing date	Jan 23, 2015
Grant date	Nov 3, 2015
Priority date	—
Expiry date	Jan 23, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D491/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to substituted azoanthracene derivatives and intermediates for the preparation thereof. The substituted azoanthracene derivatives and associated intermediates may be useful for the preparation of pharmaceutical compositions for the treatment or prevention of diseases, disorders, and conditions wherein modulation of the human GLP-1 receptor is beneficial.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.